News & events
Keep up-to-date with the latest Synthetic Biology information from across the industry
SynbiCITE and Rainbow Seed Fund congratulate CustoMem as winners of the 1st Prize in the Bio-start competition for companies using engineering biology to solve significant global problems.
On Tuesday 11th July 2017, the finals and awards for the first annual Bio-start competition will take place. Read about the finalists here.
The Rainbow Seed Fund – one of the founders of the Bio-start award – is seeking early-stage companies for high growth, high-risk investment. The RSF combines the best of the public and private sectors to capitalise companies spun out from the UK’s research base in synthetic biology.
The Institution of Engineering and Technology (IET) has launched a new journal, entitled Engineering Biology, to reflect the fact that synthetic biology/engineering biology is, fundamentally, now widely recognised as a field of engineering.
Japanese government delegation seeks SynbiCITE’s advice on start-ups creation and synthetic biology business opportunities
A recent UK visit by a high-level Japanese delegation of government officials and industrialists recognises the tremendous progress the UK has made, building on its established lead in Europe, towards becoming a major global biotech cluster.
Two start-ups' proposals have been chosen as the winners of the first competition to discover and accelerate new synthetic biology companies at the University of Bristol.
Richard Kelwick and Professor Paul Freemont comment on The Economist's article on cell-free synthetic biology “Cell-free biotech will make for better products”.
From the 15th-17th March 2017 SynbiCITE will attend a workshop to establish UK-East African collaborations in practical synthetic biology, taking plac...
December 2016 saw the 1st International Conference on Engineering Biology take place in London. Here we look back over some conference highlights and award winners.
Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics
Edinburgh, UK, 4th January 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collabora...
SynbiCITE and Rainbow Seed Fund today announce new sponsors and prizes for the Bio-start competition, designed to commercialise the engineering of biology. The addition of new sponsors increases the number of prizes available to competitors including the free use of laboratory space around the UK.
Running from February – April 2017, the Bio-start accelerator will provide direct access to connections that matter most in the industry. All entrants accepted into the programme will receive substantial mentoring and exposure to our global business and investor network.
Applications from a range of sectors across the UK continue to arrive for Bio-start, the competition to incentivise innovative early-stage companies a...
The Institute of Child Health in London will host a Synthetic Biology Innovation Forum on 11th October 2016. This event will bring together leading Sy...
‘Building a Biotech Business from Scratch’: IBioIC announces a 4-day MBA ‘More Business Acumen’ from 20-24 November in Glasgow
The Industrial Biotechnology Innovation Centre (IBioIC), in association with SynbiCITE, will hold a 4-Day MBA in Glasgow from 20-24 November, aiming to develop the entrepreneurship of future biotechnology leaders.
Prof Richard Kitney, Co-Director SynbiCITEIt is almost a decade and a half since Tom Knight introduced the concept of BioBricks, or standard biologica...
Prokarium receives £2M in Government contracts to develop new vaccines against emerging diseases and bioterrorist threats
Keele, UK, 25th July 2016 – Prokarium today announced the award of funding from the UK and Mexican Governments for the development of three new vaccin...
The CRISPR-Cas9 system has rapidly become an indispensable tool in research labs around the world. Now it is finding an application as a therapeutic.
Special offer to all SynbiCITE Partners Are you an early stage venture ready to accelerate your business? Want to be part of a global network of mento...
The entrepreneurial programme Lean LaunchPad for Synthetic Biology returns to London this autumn.
Professor Paul Freemont on BBC Radio 4 Today programme discussing latest development in synthetic biology following publication of Craig Venter's 'minimal genome' paper in Science
Minister for Life Sciences George Freeman MP visits SynbiCITE to announce the release of the UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy.
12 December 2017
Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre.
Tickets for the Bio-start Awards 2017 are on offer now, and spaces are limited. To register your place for free, visit the Bio-start Awards 2017 sign up on Eventbrite.
On May 9th and 10th, 2017 around 250 scientists, industry leaders, policy makers and ethicists gathered at the New York Genome Center for the second meeting of GP-write. GP-write is an open, international collaboration that aims to reduce by 1,000-fold within 10 years the costs of engineering and testing large genomes in cell lines. Dr David McClymont, Head of Automation, The London DNA Foundry, shares his thoughts.
The synthetic biologists from Imperial College London have re-engineered yeast cells to manufacture the nonribosomal peptide antibiotic penicillin. In laboratory experiments, they were able to demonstrate that this yeast had antibacterial properties against streptococcus bacteria.
Lab automation or robotic scientists: Dr McClymont and Professor Freemont share their views in Nature Biotechnology
Dr David McClymont, head of automation at the London DNA Foundry, and Professor Paul Freemont, Co-director of the London DNA Foundry and the EPSRC Cen...
Investing in a better future: a look forward to the SynbiCITE Investor Breakfast at the House of Lords
Engineering biology is a catalyst for growing the global bioeconomy, and represents a clear money making opportunity. It will shape our future and is ...
As 2017 kicks off, we take a look back at the last 4 months of the Bio-start competition, and at what is to come as it progresses this year.
As this Autumn’s Lean Launchpad for Synthetic Biology drew to a close, the teams described the lessons learned from the programme. William Pelton who ...
Attributed to Eleanor Chambers iGEM volunteer The 2016 Giant Jamboree took place at the Hynes Convention Center in downtown Boston last week (Oct 27-...
SynbiCITE congratulates Touchlight Genetics as the winner of Best Emerging UK Synthetic Biotech Company at the OBN’s 8th Annual Awards Ceremony held l...
SynbiCITE and Rainbow Seed Fund today announce that Dr David Lawrence, Non-executive Director at Syngenta and Chairman of the Science and Technology A...
Prokarium to Develop First Vaccine to Protect Against Sexually Transmitted and Insect-Borne Zika Infections
Keele, UK, 13th September 2016 / Prokarium today announced the start of its programme to develop an oral vaccine against Zika virus infection. Using t...
Q: What is your background?A: Scientist – I liked physics and genetics, but I was already interested in business and communication (and history) at a ...
Gabriella Santosa and Florence Gschwend were awarded the prestigious 2016 Althea PrizeIn the latest of our occasional series, we look at past particip...
Professor Paul Freemont discuses the potential sequel to the Human Genome Project: HGP-Write.
SynbiCITE and the IET are planning a joint Engineering Biology workshop and conference for December 2016.
Customem wins £10,000 for innovative use of synthetic biology to create membranes that filter pollutants from wastewater.
A recent feature in Nature focuses on the various ways industry and academia hope to automate and industrialise Synthetic Biology, including SynbiCITE's upcoming DNA Foundry.
Gen9 and SynbiCITE Announce Partnership to Accelerate Technology Commercialization through Synthetic Biology
Gen9 synthetic DNA to fuel innovations by SynbiCITE community
The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking...
InnovateUK, the UK’s innovation agency, has three forthcoming Innovation Funding Competitions that opened recently.
Q&A with Bio-Start mentor Debra Conway Managing Director, CyBio Northern Europe.Bio-Start: What in your background makes you a good mentor to the ...
A Q&A with Tara Hill of Twist Bioscience about how she started out in science and business
A Q&A with James Hallinan about his experience as a mentor with the Bio-Start engineering biology competition
As part of the conference series ‘Breakthrough science and technologies: transforming our future’, the Royal Society hosted a conference posing the question ‘Synthetic biology – does industry get it?’. Read the conference report here.
Innovation meets tradition as Steve Bates, CEO of BIA, becomes the first person to wear spider silk while being honoured at Buckingham Palace.
Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.
2017 saw another successful year for SynBioBeta London, with synthetic biology researchers, investors and enthusiasts alike flocking to London for lively talks and great networking. Read SynbiCITE's insights on the event here.
Two recent events saw SynbiCITE working in partnership with OBN to connect with new audiences; a Senior Executive Breakfast at the Royal Academy of Engineering in London in late February, and the BioTuesday on ‘Engineering Biology for a Better World’ at the Mathematical Institute in Oxford in early March. Both drew on the idea of engineering biology as a technology with the power to ‘heal us, feed us and fuel us’.
The annual SynBioBeta London Conference, now in its 5th year, will return to London from the 4th-6th April 2017. With this exciting event less than a ...
Bio-start Selects First Cohort: 15 companies join Bio-start’s inaugural synthetic biology accelerator
Bio-start is pleased to announce the 15 companies that will be joining the UK’s first synthetic biology accelerator programme. Applicants from across ...
Sometimes your liquid handling robot needs to be able to use tubes but they have to be placed in exactly the correct position every time. 3D printing ...
LGC and Desktop Genetics receive SynbiCITE funding to develop novel methods for CRISPR genome editing analysis
Desktop Genetics and LGC have been awarded funding from SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology, to develop screening and validation tools for functional genomics, cell line engineering and synthetic biology.
SynbiCITE and Rainbow Seed Fund today announce that Sir Richard Sykes, Chairman of the Royal Institution of Great Britain, Chairman of Imperial Colleg...
Synthetic biology first entered the scientific lexicon in 1970s in the wake of the then recent developments in recombinant DNA technology when Waclaw ...
SynbiCITE is proud to be sponsoring the ‘Best Emerging UK Synthetic Biotech Company’ Award at the 2016 OBN awards on the 6rd of October.
SynbiCITE and Rainbow Seed Fund announce the launch of Bio-Start, an annual competition to support early stage companies in the field of synthetic biology.
SynbiCITE reports on its recent fact-finding mission to China and the state of Sino-synbio.
The UK’s first Bio-Hackathon takes place in Cambridge this week from 21st – 25th June.
Drawing inspiration from programming.
SynbiCITE has officially launched its synthetic biology Foundry, providing automated end-to-end design, construction and validation of synthetic biologic components.
You can now watch Synbicite co-director Professor Paul Freemont deliver the Royal Society of Medicine’s annual Ellison-Cliffe Lecture.
As the summer draws to a close, the life science sector once again gears up for conference season. Here we take a look at some events we are particularly excited about:
World leading DNA technology is expanding its operations in London as it grows to meet global DNA demand
Touchlight Genetics Ltd has developed a revolutionary DNA technology that can synthetically manufacture commercial scale DNA in a two-week process – a...
On 11th of July 2017, 11 months to the day from the launch of the Bio-start competition, CustoMem was announced as the overall winner, receiving £100k. Bio-start was met with widespread enthusiasm and support, and SynbiCITE fully intend to take the competition into its second year in 2018, with new sponsors, mentors and an eager new cohort of start-ups.
A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology
A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and rapidly growing sector of the bioeconomy.
Bio-start awards over £100K in zero-equity prizes to 6 high-impact start-ups Bio-start celebrates UK innovative start-ups with commercial ideas that ...
We would like to invite you to the Breakfast Seminar Launch of SynbiCITE’s UK Synthetic Biology Start-up Survey on Friday 21st July 2017, at 9.00-10:4...
Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M. Participants included existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders.
Who owns CRISPR: this blog looks at the long and contentious battle over the intellectual property rights to this breakthrough technology.
SynbiCITE is a proud sponsor of the ‘Best Emerging UK Synthetic Biology Company’ at the OBN Awards 2017
SynbiCITE is pleased to announce once again they will be sponsoring the ‘Best Emerging UK Synthetic Biology Company’ at the 9th Annual OBN Awards, 2017. This award recognises the emerging industrial or synthetic biology company that has the most promise.
Based at Imperial College, the London DNA Foundry is a core facility at SynbiCITE, and has recently launched a new website.
Prokarium and Probiomed in UK-Mexico Collaboration to Scale-Up Manufacture of Thermostable Vaccines with a Focus on Diarrhoea
Keele, UK and Mexico City, MX, 4th January 2017 / Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture...
SynbiCITE welcomes yesterday’s announcement by the Government of an additional £2billion investment per year for UK science R&D by the end of this parliament. SynbiCITE Co-Director’s Professors Richard Kitney and Paul Fremont share their thoughts.
Professors Jay Keasling and Chris Voigt Announced as Keynote Speakers at the SynbiCITE & IET Engineering Biology Conference
The 1st International Conference on Engineering Biology, co-founded by SynbiCITE and the Institution of Engineering and Technology (IET), has announced world experts Professor Jay Keasling and Professor Chris Voigt as keynote speakers.
Engineering microenvironmental sensitive devices for targeted therapies With rapidly progressing rational design of synthetic devices, synthetic biol...
SynbiCITE, along with the BIA – the UK’s biotechnology trade association - is headed to San Francisco, USA, to promote the UK synthetic biology industry to their American counterparts, as well as industry leaders and investors.
SynbiCITE has produced the synthetic biology documentary ‘Nature Knows Best’ in partnership with Business Reporter magazine.
Oxitec winner of the 2015 Best Emerging UK SynBio Company OBN announced the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic B...
Cambridge Consultants announced the launch of a new DNA synthesis spin-out company, Evonetix. The joint venture, supported by technology entrepreneur ...
SynbiCITE is now accepting applications for the next Lean Launchpad for Synthetic Biology, which will be run from September to November 2016.
The entrepreneurial programme Lean Launchpad for Synthetic Biology returns to London this autumn. Where are last year's budding entrepreneurs now?
SynbiCITE collaborator and Lean Launchpad graduate Bento Bioworks has completed beta testing of Bento lab, their portable and affordable DNA lab, and have raised funding for their first production run.
Watch George Freeman MP, Minister for Life Sciences, launch the new strategic plan for synthetic biology 'Biodesign for the Bioeconomy' at SynbiCITE
See and hear exactly what George Freeman MP, Minister for Life Sciences, said at the launch of the Synthetic Biology Strategic Plan 2016 - 'Biodesign for the Bioeconomy'